المؤلفون: van Hooren, L., Handgraaf, S. M., Kloosterman, D. J., Karimi, E., van Mil, L., Gassama, A. A., Solsona, B. G., de Groot, M. H. P., Brandsma, D., Quail, D. F., Walsh, L. A., Borst, Gerben R, Akkari, L.

المساهمون: Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Relation: https://dx.doi.org/10.1038/s43018-023-00547-6; van Hooren L, Handgraaf SM, Kloosterman DJ, Karimi E, van Mil L, Gassama AA, et al. CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma. Nature Cancer. 2023 2023 Apr. PubMed PMID: WOS:000972819600001.; http://hdl.handle.net/10541/626335; Nature Cancer

الاتاحة: http://hdl.handle.net/10541/626335
https://doi.org/10.1038/s43018-023-00547-6

المؤلفون: van Hooren, L., Handgraaf, S. M., Kloosterman, D. J., Karimi, E., van Mil, L., Gassama, A. A., Solsona, B. G., de Groot, M. H. P., Brandsma, D., Quail, D. F., Walsh, L. A., Borst, Gerben R, Akkari, L.

المساهمون: Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands

Relation: https://dx.doi.org/10.1038/s43018-023-00547-6; van Hooren L, Handgraaf SM, Kloosterman DJ, Karimi E, van Mil L, Gassama AA, et al. CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma. Nat Cancer. 2023 Apr 20. PubMed PMID: 37081259. Epub 2023/04/21. eng.; http://hdl.handle.net/10541/626244; Nature Cancer

الاتاحة: http://hdl.handle.net/10541/626244
https://doi.org/10.1038/s43018-023-00547-6

المؤلفون: Slangen, P., Elbakary, B., Van Mil, L., De Gooijer, M., Krenning, L., Van den Broek, B., Mertz, M., Van Tellingen, O., Borst, Gerben R

المساهمون: The Netherlands Cancer Institute, Amsterdam, Netherlands

Relation: https://dx.doi.org/10.1093/neuonc/noac209.149; Slangen P, Elbakary B, Van Mil L, De Gooijer M, Krenning L, Van den Broek B, et al. Targeting the Cell-Cycle Effects of Tumor Treating Fields (Ttfields) to Increase Its Efficacy. Neuro-oncology. 2022 Nov;24:38-. PubMed PMID: WOS:000888571000152.; http://hdl.handle.net/10541/625989; Neuro-Oncology

الاتاحة: http://hdl.handle.net/10541/625989
https://doi.org/10.1093/neuonc/noac209.149

المؤلفون: Verheul, Ingrid, van Mil, L

المصدر: Verheul , I & van Mil , L 2011 , ' What determines the growth ambition of Dutch early-stage entrepreneurs? ' , International Journal of Entrepreneurial Venturing , vol. 3 , no. 2 , pp. 183-207 . https://doi.org/10.1504/IJEV.2011.039340

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL000700/RSMORG, name=RSM ORG

الاتاحة: https://pure.eur.nl/en/publications/9afeb678-1b9c-4b9b-baca-0c3c7b8888ba
https://doi.org/10.1504/IJEV.2011.039340
http://hdl.handle.net/1765/76396

المؤلفون: Verheul, Ingrid, van Mil, L

المصدر: Verheul , I & van Mil , L 2011 , ' What determines the growth ambition of Dutch early-stage entrepreneurs? ' , International Journal of Entrepreneurial Venturing , vol. 3 , no. 2 , pp. 183-207 . https://doi.org/10.1504/IJEV.2011.039340

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL000700/RSMORG, name=RSM ORG

Relation: https://pure.eur.nl/en/publications/9afeb678-1b9c-4b9b-baca-0c3c7b8888ba

الاتاحة: https://pure.eur.nl/en/publications/9afeb678-1b9c-4b9b-baca-0c3c7b8888ba
https://doi.org/10.1504/IJEV.2011.039340
http://hdl.handle.net/1765/76396